Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by KNVB9on Jun 10, 2020 5:20pm
251 Views
Post# 31135734

RE:RE:RE:Great Day! $3.62 close

RE:RE:RE:Great Day! $3.62 close

Cost and Valuation

The kits are set to be priced at $25-50 (CAD,) with a 70-80% profit margin. The company currently has LOI’s signed, totaling 4.7M units, indicating a recoup of the initial investment, with clear signs for growth.

SONA will continue to increase in value if the company can deliver on its promise to yield 20,000 test kits available per week, with the goal of scaling to 1M per week, upward of 100M per year. Value grow if the company can deliver without increasing costs beyond what is already deemed acceptable via the model of other infectious disease testing and while continuing to deliver results in 5-10 minutes.

SONA’s capacity claims have been third-party validated and await Health Canada.



This article claims that they have been 3rd party validated already???
Interesting!! GTLA

<< Previous
Bullboard Posts
Next >>